Nasal polyps impact in severe asthma patients: evidences from the SANI

Nasal polyps impact in severe asthma patients: evidences from the SANI

Bibliographic Details
Main Authors:	Giorgio Walter Canonica, Luca Malvezzi, Francesco Blasi, Pierluigi Paggiaro, Marco Mantero, Gianenrico Senna, Enrico Heffler
Format:	Article
Language:	English
Published:	Elsevier 2020-08-01
Series:	World Allergy Organization Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S1939455120302829

Similar Items

SANI-Severe Asthma Network in Italy: a way forward to monitor severe asthma
by: G. Senna, et al.
Published: (2017-04-01)

Asthma severity: the patient’s point of view
by: Gabriella Guarnieri, et al.
Published: (2024-12-01)

Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center
by: Paolo Solidoro, et al.
Published: (2022-01-01)

Frequency of Tiotropium Bromide Use and Clinical Features of Patients with Severe Asthma in a Real-Life Setting: Data from the Severe Asthma Network in Italy (SANI) Registry
by: Puggioni F, et al.
Published: (2020-11-01)

Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis
by: Enrico Heffler, et al.
Published: (2020-06-01)

Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey
by: Claudia Crimi, et al.
Published: (2023-11-01)

Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)
by: Giorgio Walter Canonica, et al.
Published: (2020-10-01)

Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis
by: Maria D'Amato, et al.
Published: (2022-05-01)

Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
by: Marco Caminati, MD, et al.
Published: (2024-08-01)

Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies
by: Giorgio Walter Canonica, et al.
Published: (2021-09-01)

Interleukin-5 in the Pathophysiology of Severe Asthma
by: Corrado Pelaia, et al.
Published: (2019-12-01)

Clinical-economic impact of mepolizumab in patients with severe hypereosinophilic asthma
by: Diego Bagnasco, et al.
Published: (2020-08-01)

Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI)
by: Giorgio Walter Canonica, MD, et al.
Published: (2025-01-01)

Release of Type 2 Cytokines by Epithelial Cells of Nasal Polyps
by: Monica Boita, et al.
Published: (2016-01-01)

Treatment strategies for asthma: reshaping the concept of asthma management
by: Alberto Papi, et al.
Published: (2020-08-01)

Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders
by: Diego Bagnasco, et al.
Published: (2023-08-01)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
by: Laidlaw TM, et al.
Published: (2023-09-01)

Outcomes of biological therapy in patients with severe asthma with chronic rhinosinusitis in Saudi Arabia: patients with nasal polyps versus those without nasal polyps
by: Usama E. Abuelhassan, et al.
Published: (2024-07-01)

Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps
by: Giovanni Paoletti, MD, et al.
Published: (2022-11-01)

Global Burden of Asthma, and Its Impact on Specific Subgroups: Nasal Polyps, Allergic Rhinitis, Severe Asthma, Eosinophilic Asthma
by: Rabe APJ, et al.
Published: (2023-10-01)

Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps
by: Diego Bagnasco, MD, PhD, et al.
Published: (2022-12-01)

Tezepelumab treatment in severe asthma with recurrent chronic rhinosinusitis with nasal polyps: Case series
by: Yoshiro Kai, MD, PhD
Published: (2025-05-01)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]
by: Laidlaw TM, et al.
Published: (2023-09-01)

Biologics in severe asthma: the role of real-world evidence from registries
by: Giovanni Paoletti, et al.
Published: (2022-06-01)

Biomarker relatability in the International Severe Asthma Network
by: David Price, et al.
Published: (2020-08-01)

Patient's Adherence and Compliance and Quality of Life During/After VIT
by: Cristoforo Incorvaia, et al.
Published: (2022-06-01)

Venom Immunotherapy and Aeroallergen Immunotherapy: How Do Their Outcomes Differ?
by: Cristoforo Incorvaia, et al.
Published: (2022-02-01)

Patient-Reported Outcomes with Benralizumab in Patients with Severe Eosinophilic Asthma and Severe Chronic Rhinosinusitis with Nasal Polyps
by: Rory Chan, et al.
Published: (2023-03-01)

Critical evaluation of asthma biomarkers in clinical practice
by: Giuseppe Guida, et al.
Published: (2022-10-01)

Improvement in Health-Related Quality of Life with Dupilumab in Patients with Moderate-to-Severe Asthma with Comorbid Chronic Rhinosinusitis with/without Nasal Polyps: An Analysis of the QUEST Study
by: Hopkins C, et al.
Published: (2022-06-01)

Olfactory impairment in Italian patients with chronic rhinosinusitis with nasal polyps: a patient-centered survey
by: Francesca Anastasi, et al.
Published: (2025-01-01)

Nasal polyps in patients with asthma: prevalence, impact, and management challenges
by: Langdon C, et al.
Published: (2016-03-01)

Evidence for interleukin-5 in nasal polyps in aspirin-induced asthma
by: Norihisa Ogata, et al.
Published: (1997-01-01)

Tezepelumab: patient selection and place in therapy in severe asthma
by: Francesco Menzella, et al.
Published: (2024-04-01)

Targeted therapy in severe asthma today: focus on immunoglobulin E
by: Pelaia G, et al.
Published: (2017-06-01)

The burden of chronic rhinosinusitis with nasal polyps and its relation to asthma in Finland
by: Sanna Toppila‐Salmi, et al.
Published: (2022-10-01)

Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
by: Aikaterini Detoraki, et al.
Published: (2021-04-01)

Could Eosinophilia predict clinical severity in nasal polyps?
by: Figen Aslan, et al.
Published: (2017-08-01)

Possible role of <it>EMID2 </it>on nasal polyps pathogenesis in Korean asthma patients
by: Pasaje Charisse Flerida, et al.
Published: (2012-01-01)

Asthma control in primary care: the results of an observational cross-sectional study in Italy and Spain
by: Maria Sandra Magnoni, et al.
Published: (2017-01-01)